Glioma cells can also select for CD8 + T cell-resistant clones within their tumor mass and can undergo immunoediting processes and acquire myeloid transcriptional programs to avoid attack from CD8 + T cells and further avoid immune attack [162, 163]. The gene discussed is CD8A; the disease is central nervous system cancer.